Life360, Inc. filings document regulatory disclosures for a Delaware technology company whose common stock trades on Nasdaq under LIF. Form 8-K reports furnish operating and financial results, Regulation FD presentation materials, material-event disclosures, material agreements, shareholder voting matters and capital-structure information.
Proxy materials describe board and executive compensation matters, equity awards, corporate governance and voting procedures. The filing record also reflects disclosure areas tied to Life360’s family safety platform, subscription metrics, advertising initiatives, legal and compliance oversight, and public-company securities reporting.
Life360, Inc. director Charles J. Prober exercised options for 7,930 shares of common stock at an exercise price of $11.18 per share on October 13, 2026, then sold 7,930 shares at $43.29 per share. The reported transactions were made under a Rule 10b5-1 trading plan adopted March 14, 2025; the plan is written and pre-established and provides for automatic sales under predetermined criteria.
Life360, Inc. director Charles J. Prober reported a proposed sale of 7,930 common shares through Fidelity Brokerage Services LLC, with an aggregate market value of $343,289.70 and an approximate sale date of October 13, 2026. The notice lists the shares as acquired from the issuer through a stock option exercise on October 13, 2026, with cash payment.
Life360, Inc. director Alex Haro exercised options for 50,000 common shares at $2.53 per share on October 6, 2026. The derivative entry listed 145,565 shares following the transaction. On the same date, he sold 48,608 shares at a weighted average of $41.41 (range $41.137–$42.135) and 1,392 shares at a weighted average of $42.36 (range $42.145–$42.74). The reported transactions were effected pursuant to a written, pre-established Rule 10b5-1 trading plan adopted June 9, 2026.
Life360, Inc. (LIF) lists a proposed sale by director Alexander Haro of 50,000 common shares, with an approximate sale date of October 6, 2026, and an aggregate market value of $2,072,045.58; NASDAQ is listed as the exchange. The shares are identified as acquired through a stock option exercise on October 6, 2026, with cash payment. The notice also reports that Alexander Haro sold 50,000 common shares on September 21, 2026, for gross proceeds of $2,044,285.00.
Life360, Inc. (LIF) ownership disclosure was amended by Paradice Investment Management Pty Ltd, which reported beneficial ownership of 3,612,414 common shares, equal to 4.44% of the class, as of September 30, 2026. The report identifies the position as 5% or less of the class.
For Life360, Inc., director John Philip Coghlan reported that the John Coghlan Living Trust sold 3,800 common shares at a weighted-average price of $40.34 per share and 200 shares at a weighted-average price of $40.97 per share on October 1, 2026. Both sales were made under a Rule 10b5-1 trading plan adopted by Coghlan on December 8, 2025.
Life360, Inc. (LIF) director John Philip Coghlan reported a proposed sale of 12,000 common shares with an aggregate market value of $489,791. The shares are listed as acquired through private purchases. The notice also reports two prior sales during the preceding three months: 4,000 shares on August 3, 2026, for $219,259 and 4,000 shares on September 1, 2026, for $167,878.
Life360, Inc. director Alex Haro exercised options for 50,000 common shares on September 21, 2026, at $2.53 per share. That day, Haro sold 31,275 shares at a weighted-average $40.72 per share and 18,725 shares at a weighted-average $41.16 per share. The transactions were effected under a Rule 10b5-1 trading plan adopted June 9, 2026. The option position covered 195,565 shares following the exercise.
Life360, Inc. director Alexander Haro, through Fidelity Brokerage Services LLC, filed a notice to sell up to 50,000 shares of common stock under Rule 144. The planned sale is tied to a stock option exercise for cash, with an aggregate market value of $2,044,284.09 as of the filing data. The contemplated transaction is referenced with a prospective date of September 21, 2026 and would be executed on Nasdaq.
Life360, Inc. (LIF) director Charles J. Prober exercised stock options for 7,930 shares of common stock on September 14, 2026 at an exercise price of $11.18 per share, then sold 7,930 shares at $42.12 per share the same day. The options were fully vested and exercisable and the transactions were carried out under a Rule 10b5-1 trading plan adopted on March 14, 2025. Reported holdings include 3,361 restricted stock units representing contingent rights to receive common shares upon vesting.